Month: September 2020

When doing good boosts health, well-being

Performing acts of kindness and helping other people can be good for people’s health and well-being, according to new research. But not all good-hearted behavior is equally beneficial to the giver. The strength of the link depends on many factors, including the type of kindness, the definition of well-being, and the giver’s age, gender and […]

Published on September 3, 2020

Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease

Kinases are an intensively studied drug target class in current pharmacological research as evidenced by the large number of kinase inhibitors being assessed in clinical trials. Kinase-targeted therapies have potential for treatment of a broad array of indications including central nervous system (CNS) disorders. In addition to the many variables which contribute to identification of […]

Published on September 3, 2020

Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients

Alzheimer’s disease (AD) is a debilitating neurodegenerative disease characterized by the accumulation of two proteins in fibrillar form: amyloid-β (Aβ) and tau. Despite decades of intensive research, we cannot yet pinpoint the exact cause of the disease or unequivocally determine the exact mechanism(s) underlying its progression. This confounds early diagnosis and treatment of the disease. […]

Published on September 3, 2020